![Bayer HealthCare CONTOUR NEXT LINK User Manual Download Page 37](http://html.mh-extra.com/html/bayer-healthcare/contour-next-link/contour-next-link_user-manual_2712803037.webp)
TECHNICAL,
SER
VICE & CARE
67
www.bayerdiabetes.com/us
Need Help? Call toll free: 1.800.348.8100 (available 24 hours a day, 7 days a week)
TECHNICAL,
SER
VICE & CARE
66
WARNING
Information for Safety: If you are experiencing
any of these symptoms, test your blood sugar.
If your test result is under 50 mg/dL or above
250 mg/dL, contact your health care
professional immediately.
For additional information and a complete list of
symptoms, contact your health care professional
or refer to the website of the American Diabetes
Association: www.diabetes.org.
System Performance Information
Symptoms of High and Low Blood Sugar
Symptoms of High and Low
Blood Sugar
You can better understand your test results by being
aware of the symptoms of high or low blood sugar.
According to the American Diabetes Association, some
of the most common symptoms are:
Low blood
sugar
(Hypoglycemia):
High blood
sugar
(Hyperglycemia):
Ketones
(Ketoacidosis):
• shakiness
• sweating
• fast heartbeat
• blurred vision
• confusion
• passing out
• irritability
• seizure
• extreme
hunger
• dizziness
• frequent
urination
• excessive
thirst
• blurred vision
• increased
fatigue
• hunger
• shortness of
breath
• nausea or
vomiting
• very dry
mouth
System Performance Information
Capillary samples may be drawn from the fingertip
and palm of the hand. The test provides a quantitative
measurement of glucose in whole blood from
20 to 600 mg/dL.
CAUTION:
• For
in vitro
diagnostic use only.
•
Potential Biohazard:
The C
ONTOUR
®
N
EXT
LINK meter is intended for
use with only one person. All products or objects
that come in contact with human blood, even
after cleaning, should be handled as if capable of
transmitting infectious diseases.
System Requirements
Computer with High-Power USB port
For latest compatibility:
www.bayerdiabetes.com/us
84359751_CntrNextLINK_UG_EN_FpBp_v4.indd 66-67
84359751_CntrNextLINK_UG_EN_FpBp_v4.indd 66-67
3/29/12 12:19 PM
3/29/12 12:19 PM